Страна: Канада
мова: англійська
Джерело: Health Canada
CLOMIPRAMINE HYDROCHLORIDE
ACTAVIS PHARMA COMPANY
N06AA04
CLOMIPRAMINE
25MG
TABLET
CLOMIPRAMINE HYDROCHLORIDE 25MG
ORAL
100
Prescription
TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS
Active ingredient group (AIG) number: 0109212003; AHFS:
CANCELLED POST MARKET
2016-02-19
PRODUCT MONOGRAPH PR ACT CLOMIPRAMINE ® (CLOMIPRAMINE HYDROCHLORIDE) 10 MG, 25 MG AND 50 MG TABLETS ANTIDEPRESSANT / ANTIOBSESSIONAL Actavis PharmaCompany DATE OF REVISION: 6733 Mississauga Road, Suite 400 February 18, 2015 Mississauga, Ontario Canada, L5N 6J5 Control # 181494 - 2 - PRODUCT MONOGRAPH PR ACT CLOMIPRAMINE ® (clomipramine hydrochloride) 10 mg, 25 mg and 50 mg tablets THERAPEUTIC CLASSIFICATION Antidepressant Antiobsessional ACTIONS AND CLINICAL PHARMACOLOGY ACT CLOMIPRAMINE (clomipramine hydrochloride) is a tricyclic agent with both antidepressant and antiobsessional properties. Like other tricyclics, clomipramine inhibits norepinephrine and serotonin uptake into central nerve terminals, possibly by blocking the membrane-pump of neurons. Clomipramine thereby increases the concentration of transmitter monoamines at receptor sites. Clomipramine is presumed to influence depression and obsessive and compulsive behavior through its effects on serotonergic neurotransmission. The actual neurochemical mechanism is unknown, but clomipramine’s capacity to inhibit serotonin reuptake is thought to be important. Clomipramine appears to have a mild sedative effect that may be helpful in alleviating the anxiety component often accompanying depression. As with other tricyclic compounds, ACT CLOMIPRAMINE possesses anticholinergic properties which are responsible for certain side effects. It also has weak antihistamine and antiserotonin properties, lowers the convulsive threshold, potentiates the effect of norepinephrine and other drugs acting on the central nervous system, has a quinidine-like effect on the heart and may impair cardiac conduction. The action of ACT CLOMIPRAMINE on the human electroencephalogram is one of desynchronization. Clomipramine causes a persistent increase in the frequency of shifts into stage I sleep and produces marked reduction or suppression of rapid eye movement sleep (REM or paradoxical sleep). Partial recovery occurs within 3 to 4 weeks as does a rebound after drug withdrawal whic Прочитайте повний документ